IP Library › Granted Patent US 10,144,858
Granted Patent B2
US 10,144,858 · App. 15/505,578 · Granted Dec 4, 2018

Methods and compositions including a curable resin and organophilically-modified clay for subterranean oil well applications

Inventors: Herron J. Kennedy (Boulder, CO); Paul Joseph Jones (Houston, TX); Lucas David Albrighton (Centennial, CO)
Assignee: Halliburton Energy Seervices, Inc.
C09K8/44C04B24/425C04B26/10C04B26/14C04B28/021C09K8/467C09K8/48C09K8/62E21B33/138E21B33/14E21B43/26C09K2208/08C09K2208/26C09K2208/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,144,858
App. No.
15/505,578
Granted
Dec 4, 2018
Kind
B2
Abstract

Compositions including a curable resin and organophilically-modified clay for subterranean oil well applications and methods of using the same. A method of treating a subterranean formation including placing in a subterranean formation a curable composition that includes at least one of a curable organic resin and a thermosetting polymer. The curable composition also includes an organophilically-modified clay.

Claims (31)

1. A method of treating a subterranean formation, the method comprising:

placing a curable composition in a subterranean formation, wherein the curable composition comprises:

at least one of a curable organic resin and a thermosetting polymer; and

an organophilically-modified clay comprising an organophilic-modification compound or an ion thereof,

wherein the organophilic-modification compound is at least one of a substituted or unsubstituted (C 10 -C 50 ) fatty acid or a salt thereof, a tri- or tetra-(C 1 -C 50 ) hydrocarbylammonium salt, a tri- or tetra-(C 1 -C 50 ) hydrocarbylphosphonium salt, or combinations thereof, and

wherein each tri- or tetra-(C 1 -C 50 ) hydrocarbylammonium salt, and tri- or tetra-(C 1 -C 50 ) hydrocarbylphosphonium salt is independently selected, is substituted or unsubstituted, and is interrupted by 0, 1, 2, or 3 atoms chosen from at least one of —O—, —S—, substituted or unsubstituted —NH—, or combinations thereof.

2. The method of claim 1 , wherein the organophilic-modification compound comprises a (C 10 -C 50 ) fatty acid salt.

3. The method of claim 1 , wherein the organophilic-modification compound comprises magnesium stearate and zinc stearate.

4. The method of claim 1 , wherein the organophilic-modification compound comprises at least one of a tri- or tetra-(C 1 -C 50 ) hydrocarbylammonium salt, a tri- or tetra-(C 1 -C 50 )alkyl- or alkenylphosphonium salt, or a combination thereof.

5. The method of claim 1 , wherein the organophilic-modification compound comprises at least one of a trimethyl stearyl ammonium salt, dodecyltrimethylammonium bromide, hexadecyltrimethylammonium bromide, tetradecyltrimethylammonium bromide, tetraphenylphosphonium bromide, or combinations thereof.

6. The method of claim 1 , wherein the curable composition comprises an amine component that is at least one of diethyltoluenediamine, polyoxypropylene diamine, 2,4,6-tris(dimethylaminomethyl)phenol, or any combination thereof.

7. The method of claim 1 , further comprising curing the curable composition, to provide a cured product of the curable composition, wherein the curing occurs at least partially above-surface.

8. The method of claim 1 , further comprising curing the curable composition, to provide a cured product of the curable composition, wherein the curing occurs at least partially in the subterranean formation.

9. The method of claim 1 , wherein the curable organic resin comprises a diepoxide-substituted phenyl(C 1 -C 10 ) hydrocarbylphenyl, wherein the phenyl and (C 1 -C 10 ) hydrocarbyl are each independently substituted or unsubstituted.

10. The method of claim 1 , wherein the curable organic resin comprises diglycidyl ether of bisphenol A, cyclohexanedimethanol diglycidyl ether, or a combination thereof.

11. The method of claim 1 , wherein the organophilically-modified clay has a density of about 200 kg/m 3 to about 500 kg/m 3 .

12. The method of claim 1 , wherein the organophilically-modified clay has a particle size of about 1 micron to about 500 microns.

13. The method of claim 1 , wherein at least one organophilic-modification compound or an ion thereof is about 10 wt % to about 50 wt % of the at least one organophilically-modified clay.

14. The method of claim 1 , wherein the curable composition has a density of about 200 kg/m 3 to about 3,000 kg/m 3 .

15. The method of claim 1 , wherein the organophilically-modified clay is about 1 wt % to about 20 wt % of the curable composition.

16. The method of claim 1 , wherein the organophilically-modified clay comprises at least one of kaolinite, montmorillonite, illite, and chlorite.

17. The method of claim 1 , further comprising fracturing at least part of the subterranean formation with the curable composition to form at least one subterranean fracture.

18. The method of claim 1 , further comprising cementing or repairing a wellbore in the subterranean formation.

19. A system for performing the method of claim 1 , the system comprising:

a tubular disposed in the subterranean formation; and

a pump configured to pump the curable composition in the subterranean formation through the tubular.

20. A curable composition for treatment of a subterranean formation, composition comprising:

at least one of a curable organic resin and a thermosetting polymer; and

an organophilically-modified clay comprising an organophilic-modification compound or an ion thereof,

wherein the organophilic-modification compound is at least one of a substituted or unsubstituted (C 10 -C 50 ) fatty acid or a salt thereof, a tri- or tetra-(C 1 -C 50 ) hydrocarbylammonium salt, a tri- or tetra-(C 1 -C 50 ) hydrocarbylphosphonium salt, or combinations thereof, and

wherein each tri- or tetra-(C 1 -C 50 ) hydrocarbylammonium salt, and tri- or tetra-(C 1 -C 50 ) hydrocarbylphosphonium salt is independently selected, is substituted or unsubstituted, and is interrupted by 0, 1, 2, or 3 atoms chosen from at least one of —O—, —S—, substituted or unsubstituted —NH—, or combinations thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2017
From: KENNEDY, HERRON J.; JONES, PAUL JOSEPH; ALBRIGHTON, LUCAS DAVID
To: HALLIBURTON ENERGY SERVICES, INC.
Reel/Frame 041331/0497 →
Continuity (1)
Related Publication 20170247598A1 · Aug 31, 2017
Cited By (8)
US 12,559,667 US 12,570,889 US 12,617,998 US 12,709,705 US 12,715,811 US 12,735,621 US 12,735,622 US 12,735,624